American Oriental Bioengineering, Inc. (AOBI)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2012 | -59.72 Million USD | 12.8% |
| 2011 | -68.49 Million USD | -519.13% |
| 2010 | 16.34 Million USD | -60.55% |
| 2009 | 41.42 Million USD | -13.36% |
| 2008 | 47.8 Million USD | 10.43% |
| 2007 | 43.29 Million USD | 48.25% |
| 2006 | 29.2 Million USD | 117.49% |
| 2005 | 13.42 Million USD | 72.77% |
| 2004 | 7.77 Million USD | 68.88% |
| 2003 | 4.6 Million USD | 308.23% |
| 2002 | 1.12 Million USD | 356.02% |
| 2001 | 247.19 Thousand USD | 145.98% |
| 2000 | -537.58 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2013 Q1 | -21.11 Million USD | 41.19% |
| 2013 Q3 | -21.17 Million USD | -64.92% |
| 2013 Q2 | -12.84 Million USD | 39.19% |
| 2012 Q1 | -17.15 Million USD | 78.18% |
| 2012 FY | -59.72 Million USD | 12.8% |
| 2012 Q4 | -35.9 Million USD | -287.8% |
| 2012 Q3 | 19.11 Million USD | 174.14% |
| 2012 Q2 | -25.78 Million USD | -50.3% |
| 2011 Q4 | -78.63 Million USD | -1127.39% |
| 2011 FY | -68.49 Million USD | -519.13% |
| 2011 Q3 | 7.65 Million USD | 113.73% |
| 2011 Q2 | 3.58 Million USD | 287.49% |
| 2011 Q1 | 924.15 Thousand USD | -66.55% |
| 2010 Q2 | 5.12 Million USD | 64.07% |
| 2010 Q3 | 5.33 Million USD | 4.03% |
| 2010 Q4 | 2.76 Million USD | -48.17% |
| 2010 Q1 | 3.12 Million USD | -73.24% |
| 2010 FY | 16.34 Million USD | -60.55% |
| 2009 Q2 | 13.22 Million USD | 68.17% |
| 2009 FY | 41.42 Million USD | -13.36% |
| 2009 Q4 | 11.67 Million USD | 16.41% |
| 2009 Q1 | 7.86 Million USD | -2.17% |
| 2009 Q3 | 10.02 Million USD | -24.21% |
| 2008 FY | 47.8 Million USD | 10.43% |
| 2008 Q1 | 9.42 Million USD | -38.28% |
| 2008 Q4 | 8.04 Million USD | -51.22% |
| 2008 Q3 | 16.48 Million USD | 18.93% |
| 2008 Q2 | 13.85 Million USD | 47.1% |
| 2007 Q3 | 11.94 Million USD | 23.53% |
| 2007 Q4 | 15.26 Million USD | 27.81% |
| 2007 Q1 | 6.44 Million USD | -40.25% |
| 2007 FY | 43.29 Million USD | 48.25% |
| 2007 Q2 | 9.66 Million USD | 49.98% |
| 2006 Q4 | 10.78 Million USD | 42.89% |
| 2006 FY | 29.2 Million USD | 117.49% |
| 2006 Q3 | 7.55 Million USD | 29.58% |
| 2006 Q2 | 5.82 Million USD | 18.52% |
| 2006 Q1 | 4.91 Million USD | 17.68% |
| 2005 Q4 | 4.17 Million USD | 12.61% |
| 2005 Q1 | 2.18 Million USD | -20.97% |
| 2005 Q2 | 3.35 Million USD | 53.71% |
| 2005 Q3 | 3.7 Million USD | 10.55% |
| 2005 FY | 13.42 Million USD | 72.77% |
| 2004 Q3 | 2.24 Million USD | 48.64% |
| 2004 Q2 | 1.5 Million USD | 19.66% |
| 2004 Q1 | 1.26 Million USD | 40.17% |
| 2004 FY | 7.77 Million USD | 68.88% |
| 2004 Q4 | 2.76 Million USD | 23.27% |
| 2003 Q4 | 898.92 Thousand USD | -27.72% |
| 2003 Q1 | 1.16 Million USD | 380.23% |
| 2003 Q2 | 1.28 Million USD | 10.25% |
| 2003 Q3 | 1.24 Million USD | -3.56% |
| 2003 FY | 4.6 Million USD | 308.23% |
| 2002 Q3 | 273.26 Thousand USD | 247.05% |
| 2002 Q1 | - USD | -100.0% |
| 2002 FY | 1.12 Million USD | 356.02% |
| 2002 Q4 | 243.56 Thousand USD | -10.87% |
| 2002 Q2 | -185.83 Thousand USD | 0.0% |
| 2001 Q2 | 129.93 Thousand USD | 221.82% |
| 2001 FY | 247.19 Thousand USD | 145.98% |
| 2001 Q4 | 284.28 Thousand USD | 640.61% |
| 2001 Q3 | -52.58 Thousand USD | -140.47% |
| 2001 Q1 | -106.66 Thousand USD | 12.79% |
| 2000 FY | -537.58 Thousand USD | 0.0% |
| 2000 Q1 | -405.76 Thousand USD | 0.0% |
| 2000 Q2 | -147.59 Thousand USD | 63.62% |
| 2000 Q3 | 138.08 Thousand USD | 193.56% |
| 2000 Q4 | -122.3 Thousand USD | -188.57% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4372.369% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -755.317% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 212.734% |
| Nascent Biotech, Inc. | -2.08 Million USD | -2760.847% |
| Rebus Holdings, Inc. | -1.02 Million USD | -5755.431% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 191.698% |
| Qrons Inc. | -789.34 Thousand USD | -7466.431% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -9344.139% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 4.59% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -14275.07% |
| Skye Bioscience, Inc. | -37.64 Million USD | -58.655% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 20.327% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -808.218% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -21745.267% |
| SQZ Biotechnologies Company | -79.46 Million USD | 24.84% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -1964.912% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -3180.663% |
| Mesoblast Limited | -87.95 Million USD | 32.096% |
| Marizyme, Inc. | -65.34 Million USD | 8.603% |
| Genus plc | 7.9 Million USD | 856.018% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -448.355% |
| Pharming Group N.V. | -10.54 Million USD | -466.225% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -2652.558% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1509.747% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -575.321% |
| ContraFect Corporation | -65.15 Million USD | 8.331% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1122.362% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -3357.421% |
| IMV Inc. | -36.48 Million USD | -63.695% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -641.039% |
| MultiCell Technologies, Inc. | -380.07 USD | -15714214.995% |
| ONE Bio Corp. | 8.67 Million USD | 788.349% |
| Accustem Sciences Inc. | -3.74 Million USD | -1494.2% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -15.541% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -4613.424% |
| Q BioMed Inc. | -2.05 Million USD | -2810.462% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1499.93% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -2408.553% |
| Biomind Labs Inc. | -1.21 Million USD | -4818.427% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -1825.528% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -655.722% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -2964.021% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -398707.405% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -276.307% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -926.694% |
| GB Sciences, Inc. | -1.36 Million USD | -4286.165% |
| Alpha Cognition Inc. | -13.77 Million USD | -333.655% |
| HST Global, Inc. | -146.21 Thousand USD | -40749.051% |
| CSL Limited | 2.64 Billion USD | 102.261% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -3303.601% |
| Halberd Corporation | -79.67 Thousand USD | -74860.336% |
| Enzolytics Inc. | -2.17 Million USD | -2643.684% |
| Agentix Corp. | -1.37 Million USD | -4246.159% |
| Resverlogix Corp. | -3.61 Million USD | -1554.443% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1783.229% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 79.758% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 61044.283% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 962.511% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1403.285% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -1873.653% |
| AVAX Technologies, Inc. | -6.41 Million USD | -831.223% |
| Zenith Capital Corp. | -10.59 Million USD | -463.66% |
| Genscript Biotech Corporation | -95.47 Million USD | 37.445% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -256871.848% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1340.577% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -98716.668% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -2878.652% |
| Kadimastem Ltd | -3.3 Million USD | -1705.812% |
| Helix BioMedix, Inc. | -1.05 Million USD | -5555.509% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1463.901% |
| BioStem Technologies, Inc. | -8.48 Million USD | -604.061% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -13431.851% |
| LadRx Corporation | 400.44 Thousand USD | 15014.831% |
| Cell Source, Inc. | -5.32 Million USD | -1022.402% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5935.362% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5935.362% |
| NovAccess Global Inc. | -4.76 Million USD | -1152.318% |
| Affymax, Inc. | -14.42 Million USD | -314.07% |
| Itoco Inc. | -1.86 Million USD | -3095.589% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1244.399% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -3478.514% |
| Mobile Lads Corp. | -2.26 Million USD | -2538.873% |
| CytoDyn Inc. | -49.84 Million USD | -19.832% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -75470.201% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -26080.766% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -6243.447% |
| SYBLEU INC | -180.3 Thousand USD | -33024.832% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -3603.356% |
| International Stem Cell Corporation | -131 Thousand USD | -45491.906% |
| Bioxytran, Inc. | -4.28 Million USD | -1295.453% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -109948.27% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -2260.457% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -24.242% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -2725.232% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -7548.405% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1785.271% |
| Neutra Corp. | -233.46 Thousand USD | -25482.163% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -194.344% |
| PureTech Health plc | -65.69 Million USD | 9.09% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -180.842% |
| IXICO plc | -1.17 Million USD | -4970.068% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -501.646% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -4.547% |
| CSL Limited | 2.64 Billion USD | 102.261% |
| Cellectis S.A. | -103.17 Million USD | 42.112% |